Cradel Pharmaceuticals Pvt Ltd, a active private limited company, was established on 21 February 1991 in Pailan Hut, West Bengal, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24233WB1991PTC050938. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹40.00 K .
It upholds a compliant status. Employing 110 professional, Its leadership includes Manab Kumar Bakshi (Director), Roochira Guha (Director), Neelanjana Bindra (Director). Past directors included Krishna Bakshi. It holds ₹9.07 Cr open charges and ₹32.44 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 247, Diamond Harbour Road, P.O- Pailan Hut, Raspunja, South 24 Parganas, Pailan Hut, West Bengal, 700104.
U24233WB1991PTC050938
050938
21 February 1991
₹5.00 M
₹40.00 K
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Cradel Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manab Kumar Bakshi | Director | 21 Feb 1991 | Current |
| Roochira Guha | Director | 16 Jan 2019 | Current |
| Neelanjana Bindra | Director | 22 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cradel Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Cradel Pharmaceuticals had a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹90,700,000.00
₹324,414,507.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2023 | Hdfc Bank Limited | ₹1.70 M | Open |
| 02 Sep 2022 | Hdfc Bank Limited | ₹8.90 Cr | Open |
| 28 Jun 2021 | Tata Capital Financial Services Limited | ₹6.50 Cr | Satisfied |
| 20 Jun 2018 | Others | ₹5.92 Cr | Satisfied |
| 18 Sep 2014 | Axis Bank Limited | ₹4.15 Cr | Satisfied |
Explore comprehensive loan charge details -
Cradel Pharmaceuticals has a workforce of 110 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cradel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cradel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cradel Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Cradel Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.70 M with Charge ID 100817323 was registered on 29 Aug 2023. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 89.00 M registered on 02 Sep 2022 with Charge ID 100617525 was modified on 09 Feb 2023. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 89.00 M with Charge ID 100617525 was registered on 02 Sep 2022. was documented.
The activity A charge registered on 28 Jun 2021 via Charge ID 100455870 with Tata Capital Financial Services Limited was fully satisfied on 26 Aug 2022. was completed.
The CIN of Cradel Pharmaceuticals Pvt Ltd is U24233WB1991PTC050938.
Cradel Pharmaceuticals Pvt Ltd is headquartered at 247, Diamond Harbour Road, P.O- Pailan Hut, Raspunja, South 24 Parganas, Pailan Hut, West Bengal, 700104.
Cradel Pharmaceuticals Pvt Ltd was incorporated on 21 February 1991.
The current directors of Cradel Pharmaceuticals Pvt Ltd are
The primary industry of Cradel Pharmaceuticals Pvt Ltd is Manufacturing.
Cradel Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Cradel Pharmaceuticals Pvt Ltd is ₹5.00 M, and the paid-up capital is ₹40.00 K .
The compliance status of Cradel Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX